| Description |
The controlled release of a pharmaceutical active can be a vital tool in ensuring the safety and efficacy of a new or existing treatment. Developing new methods of controlled release is important to prolong the duration of action and can help to minimise adverse reactions, maximise effectiveness and increase a drug's lifespan. Make sure you attend SMi’s 7th Controlled Release conference in order to ensure that you have the ultimate knowledge on these new and vital methods.
This year’s expert speaker line-up will include:
•Dr Ian Wilding, Special Professor, School of Pharmacy, Nottingham University & President, Ian Wilding Associates Limited
•Professor Howard Stevens, Emeritus Professor of Drug Delivery, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde
•Dr Paul Ashton, President & CEO, pSivida
•Professor Gregor Cevc, Chief Executive Officer, IDEA AG
•Dr Mario Maio, Head of Formulation and Process Development, Merck*
•Gerben Moolhuizen, Chief Business Officer, OctoPlus
•Dr Andreas Schatzlein, Reader in Cancer Pharmacology, The School of Pharmacy, University of London
•Dr Peter Scholes, VP Pharmaceutical Sciences, Quotient Clinical Ltd
•Alan Johnson, Partner, Bristows
•Dr Thomas Keller, Director - Biophysical Sensors & Nanomaterials PCD, GlaxoSmithKline
•Dr Hassan Mohammad, Principal Scientist, Mundipharma International
•Dr Jens Uhlemann, Head of Product Design & Nanotechnology, Bayer Technology Services
•Katie Amssoms, Senior Scientist, Tibotec BVBA
Plus pre-conference workshop in association with InnovateLegal
Controlled release formulations: Patent strategies and opportunities for generic and biosimilar product development
27th April 2010, Crowne Plaza Hotel - St James, London
For more information on our expert speaker line-up or to view the full conference programme please visit our website at: www.smi-online.co.uk/2010controlled12.asp
Alternatively, contact Zain Philbey: +44 (0) 20 7827 6722 email: zphilbey@smi-online.co.uk
|
|
